Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study
Seema Naik(CHRISTUS Transplant Institute), Rammurti T. Kamble(Baylor College of Medicine), Joshua A. Hill(Seattle Pacific University), Marcie Riches(Medical College of Wisconsin), Siddhartha Ganguly(University of Kansas Medical Center), Kristin Page(Medical College of Wisconsin), Paul Shaughnessy(CHRISTUS Transplant Institute), Andrew Daly, Helen E. Heslop(Texas Children's Hospital), Carlos Bachier, Saurabh Chhabra(Medical College of Wisconsin), Parameswaran Hari(Medical College of Wisconsin), Nelson J. Chao(Duke University), Amer Beitinjaneh(University of Miami), Michael Boeckh(Fred Hutch Cancer Center), Jan Černý(Worcester Memorial Hospital), Jean A. Yared(University of Maryland, Baltimore), César O. Freytes(CHRISTUS Transplant Institute), Parastoo B. Dahi(Memorial Sloan Kettering Cancer Center), Sachiko Seo(National Cancer Center Hospital East), Celalettin Üstün(Rush University Medical Center), Minoo Battiwalla(Sarah Cannon), Per Ljungman(Karolinska University Hospital), Jan Storek(University of Washington), Valerie I. Brown(BC Children's Hospital), Jeffery J. Auletta(Nationwide Children's Hospital), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bipin N. Savani(Vanderbilt University Medical Center), Min Chen(Novartis (Switzerland)), Soyoung Kim(Medical College of Wisconsin), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Hillard M. Lazarus(University Hospitals of Cleveland), Kwang Woo Ahn(Medical College of Wisconsin)
Cited by 27
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
|Biology of Blood and Marrow Transplantation|2009|1.8k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k